BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7065730)

  • 1. Chloroquine retinopathy: is there a safe daily dose?
    Marks JS
    Ann Rheum Dis; 1982 Feb; 41(1):52-8. PubMed ID: 7065730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed onset chloroquine retinopathy: case report.
    Martin LJ; Bergen RL; Dobrow HR
    Ann Ophthalmol; 1978 Jun; 10(6):723-6. PubMed ID: 677653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chloroquine retinopathy: preventable by monitoring the maximum daily dose].
    Ochsendorf FR; Runne U
    Hautarzt; 1988 Jun; 39(6):341-2. PubMed ID: 3403271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RETINOPATHY DURING CHLOROQUINE THERAPY.
    Wilson W
    Br J Ophthalmol; 1961 Nov; 45(11):756-8. PubMed ID: 18170732
    [No Abstract]   [Full Text] [Related]  

  • 5. The blood-retinal barrier in chloroquine retinopathy.
    Raines MF; Bhargava SK; Rosen ES
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ophthalmologic screening history and vision-targeted health status of patients suffering from chloroquine maculopathy].
    Bergholz R; Rüther K; Tillack H; Joussen AM; Schroeter J
    Ophthalmologe; 2013 Jul; 110(7):654-62. PubMed ID: 22972175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chloroquine retinopathy].
    François J; de Rouck A; Cambie E; de Laey JJ
    Ophthalmologica; 1972; 165(2):81-99. PubMed ID: 4539289
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors associated with chloroquine-induced retinopathy in rheumatic diseases.
    Araiza-Casillas R; Cárdenas F; Morales Y; Cardiel MH
    Lupus; 2004; 13(2):119-24. PubMed ID: 14995005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity.
    Finbloom DS; Silver K; Newsome DA; Gunkel R
    J Rheumatol; 1985 Aug; 12(4):692-4. PubMed ID: 4057189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for chloroquine-associated retinopathy among missionaries on long-term malaria chemoprophylaxis.
    Lange WR; Frankenfield DL; Moriarty-Sheehan M; Contoreggi CS; Frame JD
    Am J Trop Med Hyg; 1994 Oct; 51(4):389-92. PubMed ID: 7943562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine-induced bull's eye maculopathy.
    Lai WW; Lam DS
    Hong Kong Med J; 2005 Feb; 11(1):55-7. PubMed ID: 15687518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose relationships in patients with early chloroquine retinopathy.
    Easterbrook M
    J Rheumatol; 1987 Jun; 14(3):472-5. PubMed ID: 3625628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic methods for chloroquine diphosphate induced retinopathy in systemic lupus erythematosus].
    Rodrigues LD; Shinjo SK; Oyamada MK; Serracarbassa PD; Takahashi WY; Borba EF; Bonfá ES; Nakashima Y
    Arq Bras Oftalmol; 2009; 72(3):313-20. PubMed ID: 19668959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of color vision defects in chloroquine retinopathy.
    Vu BL; Easterbrook M; Hovis JK
    Ophthalmology; 1999 Sep; 106(9):1799-803; discussion 1804. PubMed ID: 10485553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual function and long-term chloroquine treatment.
    Bartel PR; Roux P; Robinson E; Anderson IF; Brighton SW; van der Hoven HJ; Becker PJ
    S Afr Med J; 1994 Jan; 84(1):32-4. PubMed ID: 8197491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe visual loss secondary to retinal toxicity after intravenous use of bisphosphonate in an eye with known chloroquine maculopathy.
    Bursztyn LL; Masri M; Sheidow TG
    Retin Cases Brief Rep; 2014; 8(4):322-5. PubMed ID: 25372538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
    Rüther K; Foerster J; Berndt S; Schroeter J
    Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigmentary skin changes associated with ocular chloroquine toxicity in Ghana.
    Bentsi-Enchill KO
    Trop Geogr Med; 1980 Sep; 32(3):216-20. PubMed ID: 7210154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed-onset chloroquine retinopathy.
    Ehrenfeld M; Nesher R; Merin S
    Br J Ophthalmol; 1986 Apr; 70(4):281-3. PubMed ID: 3964626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.